ArticlePharmacy (Basel, Switzerland)2019
Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing.
Article in Pharmacy (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Deprescribing Benzodiazepine Receptor Agonists in Older Adults and People With Cognitive Impairment: A Systematic Review.Journal of the American Geriatrics Society · 2025Pooled it
- Patient-Reported Barriers and Enablers to Deprescribing Recommendations During a Clinical Trial (Shed-MEDS).The Gerontologist · 2023Trial
- A model-based cost-effectiveness analysis of prescribing by dietitians and therapeutic radiographers in England.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Greening the curriculum: challenges in bringing environmental sustainability to pharmaceutical education.Frontiers in medicine · 2026Review
- [Telegeriatrics for chronic disease management through polypharmacy reduction in primary health careTelegeriatria para o controle de doenças crônicas por meio da redução da polifarmácia na atenção primária à saúde].Revista panamericana de salud publica = Pan American journal of public health · 2026Article
- Engaging Patients in Discussions About Medication Deprescribing.Journal of general internal medicine · 2025Article
- 'Do I actually even need all these tablets?' A qualitative study exploring deprescribing decision-making for people in receipt of palliative care and their family members.Palliative medicine · 2025Article
- Inpatient referrals to a specialist falls and syncope service: prevalence of STOPPFall FRIDs and review of deprescribing patterns.European journal of clinical pharmacology · 2025Observational
- Implementation and evaluation of specialist heart failure pharmacist prescribing clinics.International journal of clinical pharmacy · 2025Article
- Article
- Article
- Healthcare provider-related perceptions toward deprescribing inappropriate medications among older adult outpatients.PloS one · 2024Article
- The role of INTERCheckWEB digital innovation in supporting polytherapy management.Scientific reports · 2023Article
- Factors which influence the deprescribing decisions of community-living older adults and GPs in Australia.Health & social care in the community · 2022Article
- Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.Health technology assessment (Winchester, England) · 2022Review
- Shared Decision Making with Acutely Hospitalized, Older Poly-Medicated Patients: A Mixed-Methods Study in an Emergency Department.International journal of environmental research and public health · 2022Article
- Primary care physicians' approaches to low-value prescribing in older adults: a qualitative study.BMC geriatrics · 2022Article
- Prescriber perspectives on low-value prescribing: A qualitative study.Journal of the American Geriatrics Society · 2021Article
- A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial.Metabolites · 2021Article
- Deprescribing practices in Canada: A scoping review.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPCArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deprescribing is complex and multifactorial with multiple approaches described in the literature. Internationally, there are guidelines and tools available to aid clinicians and patients to identify and safely withdraw inappropriate medications, post a shared decision-making medicines optimisation review. The increase in available treatments and use of single disease model guidelines have led to a healthcare system geared towards prescribing, with deprescribing often seen as a separate activity. Deprescribing should be seen as part of prescribing, and is a key element in ensuring patients remain on the most appropriate medications at the correct doses for them. Due to the complex nature of polypharmacy, every patient experience and relationship with medications is unique. The individual's history must be incorporated into a patient-centred medication review, in order for medicines to remain optimal through changes in circumstance and health. Knowledge of the law and appropriate recording is important to ensure consent is adequately gained and recorded in line with processes followed when initiating a medication. In recent years, with the increase in interested clinicians globally, a number of prominent networks have grown, creating crucial links for both research and sharing of good practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.